Onconome Home  
Home Our Company Our Technology Our Pipeline Collaborations Contact

Licensing & Business Development


In-licensing has been a core function for Onconome as we continuously seek and evaluate new diagnostic technologies and collaborative prospects with universities and other biotechnology companies.

Our aggressive in-licensing program focuses on novel proteomic and/or genomic biomarkers and biomarker combinations with diagnostic, prognostic, staging and/or response to treatment indications for cancer and other major diseases with unmet diagnostic needs.

We are keen to expand our partnerships with universities and other biotechnology companies to create long-term collaborations that will facilitate development and commercialization of biomarker discoveries.

If you are interested in exploring a licensing collaboration with us, please contact us at: .

     
 
photo

 
Onconome:
Home | Our Technology | Our Products | Our Company | Collaborations | Contact
Copyright © 2002-2008 Onconome, Inc. All rights reserved | Privacy